Literature DB >> 10670423

Agonist-stimulated [35S]GTPgammaS binding in brain modulation by endogenous adenosine.

R J Moore1, R Xiao, L J Sim-Selley, S R Childers.   

Abstract

Coupling of receptors to G-proteins can be assessed by the ability of specific agonists to stimulate [35S]GTPgammaS binding in both brain membranes and sections in the presence of excess GDP. In some brain regions, however, high basal activity makes it difficult to detect agonist-stimulated [35S]GTPgammaS binding. The present study suggests a modification of the assay to reduce basal [35S]GTPgammaS binding and thus increase the signal:noise ratio. Adenosine A1 receptors belong to the class of G-protein-coupled receptors that activate Gi/Go proteins in brain. In the present study, the A1 agonist R(-)N6-(2-phenylisopropyl)adenosine (R-PIA) stimulated [35S]GTPgammaS binding in brain regions known to contain A1 receptors, including cerebellum, hippocampus and dentate gyrus, medial geniculate body, superior colliculus, certain thalamic nuclei, cerebral cortex, piriform cortex, caudate-putamen, and nucleus accumbens. Treatment of sections and membranes with adenosine deaminase (ADase), which is typically used in adenosine assays to eliminate endogenous adenosine, reduced basal [35S]GTPgammaS binding. In addition, for cannabinoid and mu-opioid agonists, the percent stimulation of [35S]GTPgammaS binding was approximately doubled when ADase was included in the assay. These results suggest that endogenous adenosine contributes significantly to basal [35S]GTPgammaS binding in certain brain regions, and that this activity may be reduced by the addition of ADase, thus improving the signal:noise ratio of agonist-stimulated [35S]GTPgammaS binding.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10670423     DOI: 10.1016/s0028-3908(99)00112-4

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  12 in total

1.  Chronic baclofen desensitizes GABA(B)-mediated G-protein activation and stimulates phosphorylation of kinases in mesocorticolimbic rat brain.

Authors:  Bradley M T Keegan; Thomas J R Beveridge; Jeffrey J Pezor; Ruoyu Xiao; Tammy Sexton; Steven R Childers; Allyn C Howlett
Journal:  Neuropharmacology       Date:  2015-02-25       Impact factor: 5.250

2.  O-2050 facilitates noradrenaline release and increases the CB1 receptor inverse agonistic effect of rimonabant in the guinea pig hippocampus.

Authors:  Bernd Jergas; Kirsten Schulte; Laura Bindila; Beat Lutz; Eberhard Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-05-23       Impact factor: 3.000

3.  Anatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain.

Authors:  Estibaliz González de San Román; Iván Manuel; María Teresa Giralt; Jerold Chun; Guillermo Estivill-Torrús; Fernando Rodríguez de Fonseca; Luis Javier Santín; Isidro Ferrer; Rafael Rodríguez-Puertas
Journal:  J Neurochem       Date:  2015-04-27       Impact factor: 5.372

4.  Functional coupling between adenosine A1 receptors and G-proteins in rat and postmortem human brain membranes determined with conventional guanosine-5'-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding or [35S]GTPγS/immunoprecipitation assay.

Authors:  Yuji Odagaki; Masakazu Kinoshita; Toshio Ota; J Javier Meana; Luis F Callado; Isao Matsuoka; Jesús A García-Sevilla
Journal:  Purinergic Signal       Date:  2018-02-28       Impact factor: 3.765

5.  Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184.

Authors:  Monika Feliszek; Laura Bindila; Beat Lutz; Andreas Zimmer; Andras Bilkei-Gorzo; Eberhard Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-03-17       Impact factor: 3.000

6.  Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy.

Authors:  K W Falenski; R E Blair; L J Sim-Selley; B R Martin; R J DeLorenzo
Journal:  Neuroscience       Date:  2007-04-12       Impact factor: 3.590

Review 7.  Endocannabinoid tone versus constitutive activity of cannabinoid receptors.

Authors:  Allyn C Howlett; Patricia H Reggio; Steven R Childers; Robert E Hampson; Nadine M Ulloa; Dale G Deutsch
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

8.  Mice with deficiency of G protein gamma3 are lean and have seizures.

Authors:  William F Schwindinger; Kathryn E Giger; Kelly S Betz; Anna M Stauffer; Elaine M Sunderlin; Laura J Sim-Selley; Dana E Selley; Sarah K Bronson; Janet D Robishaw
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

9.  Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors.

Authors:  Alexander F Hoffman; Nora Laaris; Masahito Kawamura; Susan A Masino; Carl R Lupica
Journal:  J Neurosci       Date:  2010-01-13       Impact factor: 6.167

10.  Regional differences in mu and kappa opioid receptor G-protein activation in brain in male and female prairie voles.

Authors:  T J Martin; T Sexton; S A Kim; A L Severino; C M Peters; L J Young; S R Childers
Journal:  Neuroscience       Date:  2015-10-30       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.